Flora Growth Corp.
FLGC | NASDAQ
$7.79
$0.00 (0.00%)
Nov 2, 2026, 11:38 AM ET · Market open
Company Profile
Flora Growth Corp., along with its various subsidiaries, operates as a global enterprise specializing in the cultivation, processing, and advancement of medicinal cannabis and its derived products. The company distributes these offerings to a broad international client base, including pharmacies, medical clinics, and cosmetic companies. Its extensive portfolio encompasses a range of activities and products: Cannabis and Derivatives: This core segment involves the production and supply of medical-grade cannabis oil, alongside a spectrum of cannabis-infused medical and wellness items. Health and Personal Care: They develop and market skincare and beauty products, plant-based pharmaceuticals, phytotherapeutics, and dietary supplements. Furthermore, their offerings include a wide array of cannabidiol (CBD) products like edibles (gummies), topical applications, tinctures, and vaping solutions, as well as general lifestyle wellness items such as bath and body products, pet care, and sports recovery aids. Ancillary and Lifestyle Products: Flora Growth designs and sells loungewear crafted from hemp-derived fabrics and provides accessories for cannabis consumption, personal storage, and travel, catering to both vape and dry herb users. Food and Beverages: The company's diversified operations also include the distribution of juices, gourmet chocolates (featuring exotic fruits coated in chocolate and chocolate bars), and dried fruits, beans, and pulp sourced from Amazonian regions. These items reach consumers through various retail channels, including supermarkets, discount stores, coffee shops, restaurants, and airports. They also manufacture, promote, and distribute other beverage products. Pharmaceutical Initiatives: Flora Growth is involved in creating and distributing pain relief formulations and is actively pursuing the development of a pharmaceutical cannabinoid formula intended for Sars-Cov-2 prevention. Their products are marketed under several distinct brands, including JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya. Established in 2019, Flora Growth Corp. maintains its corporate headquarters in Toronto, Canada.
Key Executives
| Name | Position |
|---|---|
| Daniel Reis-Faria | Chief Executive Officer & Director |
| Dany Vaiman | Chief Financial Officer |
| Aaron Atin | Corporate Secretary |
| Manfred Ziegler | Managing Director |
| Michael Heinrich | Executive Chairman |
| Patrick Moloney | Head of Product Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 15, 2026 | EFFECT | Filing |
| Sep 04, 2026 | POS AM | Filing |
| Sep 04, 2026 | AW | Filing |
| Sep 04, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Sep 02, 2026 | EFFECT | Filing |
| Sep 02, 2026 | EFFECT | Filing |
| Sep 02, 2026 | EFFECT | Filing |
| Sep 02, 2026 | EFFECT | Filing |
| Sep 02, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Sep 02, 2026 | D | Filing |
Flora Growth Corp.
| Country | Canada |
| IPO Date | May 11, 2021 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 64 |
| CEO | Daniel Reis-Faria |
Stock Details
| Ticker Symbol | FLGC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001790169 |
| CUSIP Number | 339764300 |
| ISIN Number | CA3397643006 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove FLGC